cagrilintide semaglutide combination cagrisema phase 3 results 2024 2025 Cagrilintide–semaglutide (CagriSema) versus or in people with type 2 diabetes (REIMAGINE 2): a double-blind, randomised, controlled, study Novo Nordisk's CagriSema outperforms Ozempic

The question worth asking is whether any of it is actually working

Summary: Sweating is not a documented direct side effect of Ozempic (semaglutide), but may occur indirectly due to hypoglycaemia or gastrointestinal distress

A statistically significant increase in thyroid C-cell adenomas was observed in males and females at all dose levels, and a statistically significant increase in thyroid C-cell carcinomas was observed in males at greater than or equal to 0.01 mg/kg/day, at clinically relevant exposures

Monitoring thyroid-stimulating hormone (TSH) and free T3/T4 levels during treatment helps distinguish between medication effects and weight-related changes